Press Releases

Want to interview a scientist about a recent breakthrough at the Gladstone Institutes? Please contact Gladstone’s press-relations staff at 415 734 5000. We’ll be delighted to connect you to one or more of our researchers.

2012

Gladstone Scientists Identify Key Biological Mechanism in Multiple Sclerosis

SAN FRANCISCO, CA—November 27, 2012—Scientists at the Gladstone Institutes have defined for the first time a key underlying process implicated in multiple sclerosis (MS)—a disease that causes...

Gladstone President to Receive Prestigious Pacesetter Award

SAN FRANCISCO, CA—October 29, 2012—Gladstone President R. Sanders "Sandy" Williams, MD, will receive the ARCS Foundation’s 2012 Pacesetter Award next week for his lifelong dedication to furthering...

Gladstone, Stanford Scientists Collaborate to Block Toxic Protein that Plays Key Role in Lou Gehrig’s Disease

SAN FRANCISCO, CA—October 28, 2012— Scientists at the Gladstone Institutes and the Stanford University School of Medicine have discovered how modifying a gene halts the toxic buildup of a protein...

Gladstone Scientist Wins Nobel Prize in Medicine

SAN FRANCISCO, CA—October 8, 2012—Shinya Yamanaka MD, PhD, a senior investigator at the Gladstone Institutes—which is affiliated with the University of California, San Francisco (UCSF)—has won the...

Gladstone Scientists Discover Gene “Bursting” Plays Key Role in Protein Production

SAN FRANCISCO, CA—October 8, 2012—Scientists at the Gladstone Institutes have mapped the precise frequency by which genes get turned on across the human genome, providing new insight into the most...

Gladstone Scientists Identify Biological Mechanism that Plays Key Role in Early-Onset Dementia

SAN FRANCISCO, CA—October 8, 2012—Using animal models, scientists at the Gladstone Institutes have discovered how a protein deficiency may be linked to frontotemporal dementia (FTD)—a form of early-...

Gladstone Scientists Map the Genomic Blueprint of the Heart

SAN FRANCISCO, CA—September 13, 2012— Scientists at the Gladstone Institutes have revealed the precise order and timing of hundreds of genetic “switches” required to construct a fully functional...

Gladstone-Led Study Underscores Truvada’s Potency in Preventing the Transmission of HIV

SAN FRANCISCO, CA—September 12, 2012— New research from an international team of HIV/AIDS experts has reaffirmed the effectiveness of Truvada—the first and only medication approved by the FDA for HIV...

Gladstone Scientists Develop Innovative Technique to Monitor and Decipher the Dormant AIDS Virus Concealed in Cells

SAN FRANCISCO, CA—September 11, 2012—Scientists at the Gladstone Institutes have gotten us one step closer to understanding and overcoming one of the least-understood mechanisms of HIV infection—by...

Gladstone Scientists Discover that Epilepsy Drug Reverses Memory Loss in Animal Model of Alzheimer’s Disease

SAN FRANCISCO, CA—August 6, 2012— Scientists at the Gladstone Institutes have discovered that an FDA-approved anti-epileptic drug reverses memory loss and alleviates other Alzheimer’s-related...